Searched for: person:ark3
World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid
Taylor, J; McMillan, R; Shephard, M; Setterfield, J; Ahmed, R; Carrozzo, M; Grando, S; Mignogna, M; Kuten-Shorrer, M; Musbah, T; Elia, A; McGowan, R; Kerr, A R; Greenberg, M S; Hodgson, T; Sirois, D
OBJECTIVE: To determine the efficacy and safety of interventions for mucous membrane pemphigoid (MMP). STUDY DESIGN: We conducted a systematic review from 2003 to 2013 according to the Cochrane Collaboration methodology. Randomized controlled trials (RCTs) or controlled clinical trials and observational studies were included, with diagnosis confirmed by clinical, histopathologic, and immunofluorescence criteria. The primary outcome was lesion remission or healing; several relevant secondary outcomes were also included. RESULTS: In the final analysis, 1 RCT and 32 observational studies were included. The one included RCT with a high risk of bias in multiple domains found limited evidence that pentoxifylline, combined with corticosteroid and cyclophosphamide, was more effective than standard therapy (corticosteroid + cyclophosphamide alone) for ocular MMP. We summarize here the outcomes from 32 observational studies examining 242 patients across 19 unique treatments. Interventions that show promise include rituximab and intravenous immunoglobulin. CONCLUSIONS: This systematic review is the most recent since 2003-2009. There is still lack of high-quality research providing evidence-based MMP treatments.
PMID: 25953640
ISSN: 2212-4411
CID: 1568362
Report on World Workshops on Oral Medicine (WWOM) IV and V: research themes and citation impact: WWOM VI Steering Committee
Peterson, D E; Lodi, G; Beier Jensen, S; Greenberg, M S; Hodgson, T; Kerr, A R; Wray, D; Lockhart, P B
The first World Workshop on Oral Medicine (WWOM) was held in 1988. The portfolio has continued to expand in scope and impact over the past 26 years. Five World Workshops were conducted between 1988 and 2010, focusing on creation of systematic reviews in biomedicine and health care of importance to the international oral medicine community. WWOM VI was conducted in April 2014 and further extended this modeling. This most recent Workshop also fostered creation of the inaugural joint meeting between the American Academy of Oral Medicine and the European Association of Oral Medicine, together with The British Society for Oral Medicine and the Oral Medicine Academy of Australasia. The goal of the WWOM portfolio is to strategically enhance international oral medicine research, education, and clinical practice. To this end, this report summarizes subject areas for WWOM IV (2004) and research recommendations for WWOM V (2010), as well as citation metrics relative to publications from these two conferences. The information is designed to provide research and clinical context for key issues in oral medicine as delineated by the WWOM portfolio over the past 10 years, as well as for projected outcomes of WWOM VI over the next 12 months.
PMID: 24844316
ISSN: 1601-0825
CID: 1561862
World Workshop on Oral Medicine VI: a systematic review of the treatment of mucocutaneous pemphigus vulgaris
McMillan, R; Taylor, J; Shephard, M; Ahmed, R; Carrozzo, M; Setterfield, J; Grando, S; Mignogna, M; Kuten-Shorrer, M; Musbah, T; Elia, A; McGowan, R; Kerr, A R; Greenberg, M S; Hodgson, T; Sirois, D
OBJECTIVE: To determine the efficacy and safety of interventions for pemphigus vulgaris (PV). STUDY DESIGN: We conducted a systematic review from 2003 to 2013 according to the Cochrane Collaboration methodology. Randomized controlled trials (RCTs) or controlled clinical trials (CCTs) and observational studies were conducted along with diagnosis confirmed by clinical, histopathologic, and immunofluorescence criteria. Primary outcomes were disease remission and mortality; several relevant secondary outcomes were also included. RESULTS: Fourteen RCTs or CCTs and 110 observational studies were included in the final analyses. RCTs or CCTs demonstrated considerable heterogeneity in outcome measures, and all had a high risk of bias for at least 1 of 8 domains. Of the studies, 96.8% (120) described the use of oral corticosteroids. Azathioprine and mycophenolate-mofetil were the most commonly cited treatments. An increasing number of studies described biologic therapies (rituximab, intravenous immunoglobulin [IVIg]). Evidence supporting recent comprehensive treatment guidelines was reviewed. CONCLUSIONS: We found persisting wide variations in treatment practice and inadequate quality of research supporting optimal PV treatment.
PMID: 25934414
ISSN: 2212-4411
CID: 1556022
World Workshop on Oral Medicine VI: an international validation study of clinical competencies for advanced training in oral medicine
Steele, John C; Clark, Hadleigh J; Hong, Catherine H L; Jurge, Sabine; Muthukrishnan, Arvind; Kerr, A Ross; Wray, David; Prescott-Clements, Linda; Felix, David H; Sollecito, Thomas P
OBJECTIVE: To explore international consensus for the validation of clinical competencies for advanced training in Oral Medicine. STUDY DESIGN: An electronic survey of clinical competencies was designed. The survey was sent to and completed by identified international stakeholders during a 10-week period. To be validated, an individual competency had to achieve 90% or greater consensus to keep it in its current format. RESULTS: Stakeholders from 31 countries responded. High consensus agreement was achieved with 93 of 101 (92%) competencies exceeding the benchmark for agreement. Only 8 warranted further attention and were reviewed by a focus group. No additional competencies were suggested. CONCLUSION: This is the first international validated study of clinical competencies for advanced training in Oral Medicine. These validated clinical competencies could provide a model for countries developing an advanced training curriculum for Oral Medicine and also inform review of existing curricula.
PMID: 25861956
ISSN: 2212-4411
CID: 1528942
World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction
Aliko, Ardita; Wolff, Andy; Dawes, Colin; Aframian, Doron; Proctor, Gordon; Ekstrom, Jorgen; Narayana, Nagamani; Villa, Alessandro; Sia, Ying Wai; Joshi, Revan Kumar; McGowan, Richard; Beier Jensen, Siri; Kerr, A Ross; Lynge Pedersen, Anne Marie; Vissink, Arjan
OBJECTIVE: This study aimed to systematically review the available literature on the clinical implications of medication-induced salivary gland dysfunction (MISGD). STUDY DESIGN: The systematic review was performed using PubMed, Embase, and Web of Science (through June 2013). Studies were assessed for degree of relevance and strength of evidence, based on whether clinical implications of MISGD were the primary study outcomes, as well as on the appropriateness of study design and sample size. RESULTS: For most purported xerogenic medications, xerostomia was the most frequent adverse effect. In the majority of the 129 reviewed papers, it was not documented whether xerostomia was accompanied by decreased salivary flow. Incidence and prevalence of medication-induced xerostomia varied widely and was often associated with number and dose of medications. Xerostomia was most frequently reported to be mild-to-moderate in severity. Its onset occurred usually in the first weeks of treatment. There was selected evidence that medication-induced xerostomia occurs more frequently in women and older adults and that MISGD may be associated with other clinical implications, such as caries or oral mucosal alterations. CONCLUSIONS: The systematic review showed that MISGD constitutes a significant burden in many patients and may be associated with important negative implications for oral health.
PMID: 25861957
ISSN: 2212-4411
CID: 1528952
The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI
Dawes, C; Pedersen, A M L; Villa, A; Ekstrom, J; Proctor, G B; Vissink, A; Aframian, D; McGowan, R; Aliko, A; Narayana, N; Sia, Y W; Joshi, R K; Jensen, S B; Kerr, A R; Wolff, A
This narrative review of the functions of saliva was conducted in the PubMed, Embase and Web of Science databases. Additional references relevant to the topic were used, as our key words did not generate references which covered all known functions of saliva. These functions include maintaining a moist oral mucosa which is less susceptible to abrasion, and removal of micro-organisms, desquamated epithelial cells, leucocytes and food debris by swallowing. The mucins form a slimy coating on all surfaces in the mouth and act as a lubricant during such processes as mastication, formation of a food bolus, swallowing and speaking. Saliva provides the fluid in which solid tastants may dissolve and distributes tastants around the mouth to the locations of the taste buds. The hypotonic unstimulated saliva facilitates taste recognition. Salivary amylase is involved in digestion of starches. Saliva acts as a buffer to protect oral, pharyngeal and oesophageal mucosae from orally ingested acid or acid regurgitated from the stomach. Saliva protects the teeth against acid by contributing to the acquired enamel pellicle, which forms a renewable lubricant between opposing tooth surfaces, by being supersaturated with respect to tooth mineral, by containing bicarbonate as a buffer and urea and by facilitating clearance of acidic materials from the mouth. Saliva contains many antibacterial, antiviral and antifungal agents which modulate the oral microbial flora in different ways. Saliva also facilitates the healing of oral wounds. Clearly, saliva has many functions which are needed for proper protection and functioning of the human body.
PMID: 25841068
ISSN: 1879-1506
CID: 1521032
"Scoping Up" Dental Education to Address Scientific Uncertainty: HPV and Oropharyngeal Cancer as a Case in Point
Equinda, Michele J; Northridge, Mary E; Kerr, Alexander R; Curry, Arlene R; Vernillo, Anthony T
ORIGINAL:0009504
ISSN: 2472-0062
CID: 1472842
Increasing Opportunistic Oral Cancer Screening Examinations: Findings from Focus Groups with General Dentists in Puerto Rico
Psoter, Walter J; Morse, Douglas E; Sanchez-Ayendez, Melba; Velez Vega, Carmen M; Aguilar, Maria L; Buxo-Martinez, Carmen J; Psoter, Jodi A; Kerr, Alexander R; Lane, Christina M; Scaringi, Vincent J; Elias, Augusto
This study aims to identify educational and training modalities that dentists in Puerto Rico (PR) believe will increase the quality and quantity of opportunistic oral cancer screening examinations (OCS) in dental offices on the island. The study was conducted in three phases: a systematic search of relevant literature, an expert review and consensus panel, and focus groups (FG) involving PR general dentists. To increase OCS by dentists in PR, the FG participants proposed a small group, hands-on OCS training, an integrated oral cancer course, and readily available videos, photographs, and computer simulations to further demonstrate OCS performance and facilitate differential diagnosis. OCS training requirements for licensure and re-licensure, improving OCS dentist-patient communication skills, and establishment of an oral lesion referral center were also viewed favorably. In conclusion, general dentists in our FGs believed the quality and quantity of OCS in Puerto Rico can be increased through the application of specific continuing education and training modalities.
PMCID:4257890
PMID: 24894606
ISSN: 0885-8195
CID: 1455972
Comparison of two mouthrinses in relation to salivary flow and perceived dryness
Kerr, A R; Corby, P M; Kalliontzi, K; McGuire, J A; Charles, C A
OBJECTIVE: To compare measures of dry mouth following extended use of an alcohol-based mouthrinse (LISTERINE Antiseptic [LA]) and a non-alcohol-based mouthrinse (Crest Pro-Health Rinse [CPH]) on healthy adults with "normal" salivary flow. METHODS: This single-site, randomized, observer-blinded, parallel study compared unstimulated whole salivary flow and perceived dryness following daily use at weeks 4 and 12 versus baseline. Noninferiority, between-treatment flow comparisons (0.15 mL/min margin), and between-treatment comparisons of the mean Bluestone Mouthfeel Questionnaire (BMQ) visual analog scale scores were made using analysis of covariance. RESULTS: Measures of dry mouth were comparable between mouthrinses, as demonstrated by both noninferiority of LA versus CPH flow (P < .001) and no significant differences between groups in the BMQ measures at 4 or 12 weeks. CONCLUSIONS: Extended use of an alcohol-based mouthrinse is no more likely to cause reduction in salivary flow or perceived dryness in individuals with normal salivary flow compared with a non-alcohol-based mouthrinse (CPH).
PMID: 25482548
ISSN: 2212-4411
CID: 1393782
Microbiome in Oral Epithelial Dysplasia and Squamous Cell Carcinoma [Meeting Abstract]
Saxena, Deepak; Pushalkar, Smruti; Devotta, Arun; Li, Yihong; Singh, Bhuvanesh; Kurago, Zoya Kurago; Kerr, Alexander; Yan, Wenbo; Sacks, Peter; Li, Xin
ISI:000349910203303
ISSN: 1538-7445
CID: 1598332